[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Lupus Nephritis (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Lupus Nephritis (Immunology) - Drugs in Development, 2021 SUMMARY Lupus Nephritis (Immunology) - Drugs in Development, 2021 provides an overview of the Lupus Nephritis pipeline landscape. The report p...

April 2021 90 pages

Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021 SUMMARY Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Lymphangioleiomyomatosis pip...

April 2021 30 pages

Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Lymphoblastic Lymphoma pipeline landsc...

April 2021 40 pages

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 2021

 US$ 3,000.00

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 2021 SUMMARY Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 202...

April 2021 85 pages

Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021 SUMMARY Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021 provides an overview of the Lymphoproliferative Diso...

April 2021 35 pages

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) - Drugs in Development, 2021

 US$ 3,000.00

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) - Drugs in Development, 2021 SUMMARY Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Me...

April 2021 40 pages

Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lysosoma...

April 2021 60 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Macrophage Stimulating Protein Receptor...

April 2021 35 pages

Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Macular Degeneration pipeline la...

April 2021 45 pages

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 SUMMARY Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Majo...

April 2021 170 pages

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021

 US$ 3,000.00

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021 SUMMARY Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2...

April 2021 30 pages

Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021

 US$ 2,000.00

Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 SUMMARY Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 provides an overview of the Male Sexual Dysfunction pipeli...

April 2021 30 pages

Malignant Ascites (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Malignant Ascites (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Ascites (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Ascites pipeline landscape. The report...

April 2021 30 pages

Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Fibrous Hist...

April 2021 35 pages

Malignant Glioma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Malignant Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Glioma pipeline landscape. The report pr...

April 2021 90 pages

Malignant Neoplasms (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Malignant Neoplasms (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Neoplasms (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Neoplasms pipeline landscape. The...

April 2021 45 pages

Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Pleural Meso...

April 2021 145 pages

Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Mantle Cell Lymphoma pipeline landscape. T...

April 2021 375 pages

Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Maple Syrup Ur...

April 2021 30 pages

Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Marginal Zone B-cell Lym...

April 2021 200 pages

Mast Cell Leukemia (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Mast Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Mast Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Mast Cell Leukemia pipeline landscape. The rep...

April 2021 30 pages

Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT...

April 2021 110 pages

Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021

 US$ 3,000.00

Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021 SUMMARY Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021 provides in depth analysis on Matrix Metallo...

April 2021 35 pages

Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Medullary Thyroid Cancer pipeline...

April 2021 85 pages

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021

 US$ 3,000.00

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021 SUMMARY Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis A...

April 2021 35 pages

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021 SUMMARY MELAS Syndrome (Mitochondrial Encephalomyopathy...

April 2021 35 pages

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021

 US$ 3,000.00

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021

 US$ 3,000.00

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021

 US$ 3,000.00

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021 SUMMARY Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC...

April 2021 40 pages

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranoproliferative Glomerulonephritis Type II...

April 2021 35 pages

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Developmen...

April 2021 35 pages

Memory Impairment (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Memory Impairment (Central Nervous System) - Drugs in Development, 2021 SUMMARY Memory Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Memory Impairment pi...

April 2021 35 pages

Meningioma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Meningioma (Oncology) - Drugs in Development, 2021 SUMMARY Meningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape. The report provides comprehensi...

April 2021 55 pages

Menopausal Disorders (Women's Health) - Drugs in Development, 2021

 US$ 2,000.00

Menopausal Disorders (Women's Health) - Drugs in Development, 2021 SUMMARY Menopausal Disorders (Women's Health) - Drugs in Development, 2021 provides an overview of the Menopausal Disorders pipeline...

April 2021 30 pages

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021

 US$ 3,000.00

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 SUMMARY Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Dru...

April 2021 35 pages

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Metabolic Syndrome pipel...

April 2021 60 pages

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 140 pages

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Bile Duct Cancer...

April 2021 30 pages

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Biliary T...

April 2021 95 pages

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 115 pages

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hormone Refractory (Castration Resistant, Androgen...

April 2021 325 pages

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Liver Cancer pipeline lan...

April 2021 65 pages

Metastatic Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Metastatic Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape. The...

April 2021 425 pages

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeli...

April 2021 115 pages

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Canc...

April 2021 160 pages

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pip...

April 2021 95 pages

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cel...

April 2021 170 pages

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 provides an...

April 2021 130 pages

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Uveal Melanoma pipeli...

April 2021 65 pages

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021

 US$ 3,000.00

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 SUMMARY Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 provides in depth analysis on Methyl CpG Binding Protein 2 (...

April 2021 35 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1